Variants in MARC1 and HSD17B13 reduce severity of NAFLD in children, perturb phospholipid metabolism, and suppress fibrotic pathways
Christian A Hudert, Anna Alisi, Quentin M Anstee, Annalisa Crudele, Laura G Draijer, EU-PNAFLD investigators, Samuel Furse, Jan G Hengstler, Benjamin Jenkins, Kylie Karnebeek, Deirdre A Kelly, Bart G Koot, Albert Koulman, David Meierhofer, Stuart G Snowden, Indra van Mourik, Anita Vreugdenhil, Susanna Wiegand, Jake P Mann
medRxiv 2020.06.05.20120956; doi: https://doi.org/10.1101/2020.06.05.20120956
